DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 189 filers reported holding DICERNA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $150,000 | -52.7% | 7,465 | -12.1% | 0.00% | -50.0% |
| Q2 2021 | $317,000 | +66.0% | 8,497 | +13.8% | 0.00% | +100.0% |
| Q1 2021 | $191,000 | -1.0% | 7,465 | -14.6% | 0.00% | 0.0% |
| Q4 2020 | $193,000 | +52.0% | 8,744 | +24.1% | 0.00% | 0.0% |
| Q3 2020 | $127,000 | -29.1% | 7,046 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $179,000 | +118.3% | 7,046 | +56.9% | 0.00% | +100.0% |
| Q1 2020 | $82,000 | +10.8% | 4,491 | +33.5% | 0.00% | 0.0% |
| Q4 2019 | $74,000 | +54.2% | 3,363 | 0.0% | 0.00% | – |
| Q3 2019 | $48,000 | +37.1% | 3,363 | +52.0% | 0.00% | – |
| Q2 2019 | $35,000 | +9.4% | 2,212 | 0.0% | 0.00% | – |
| Q1 2019 | $32,000 | -13.5% | 2,212 | -36.1% | 0.00% | – |
| Q4 2018 | $37,000 | +311.1% | 3,459 | +512.2% | 0.00% | – |
| Q3 2018 | $9,000 | – | 565 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 4,080,237 | $103,638,000 | 10.86% |
| Aquilo Capital Management, LLC | 1,454,686 | $36,949,000 | 7.45% |
| RTW INVESTMENTS, LP | 7,152,918 | $181,684,000 | 5.11% |
| EcoR1 Capital, LLC | 2,721,993 | $69,139,000 | 5.11% |
| BRIDGER MANAGEMENT, LLC | 1,473,568 | $37,429,000 | 3.47% |
| DAFNA Capital Management LLC | 454,236 | $11,538,000 | 3.33% |
| Parkman Healthcare Partners LLC | 300,805 | $7,640,000 | 2.15% |
| ACUTA CAPITAL PARTNERS, LLC | 170,000 | $4,318,000 | 1.25% |
| Integral Health Asset Management, LLC | 110,000 | $2,794,000 | 0.84% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,013,087 | $25,732,000 | 0.63% |